Background: Long-term right ventricular apical pacing can cause ventricular dyssynchrony and, secondarily, neurohumoral alterations and increase in cardiac morbimortality.
Introduction
Currently, cardiac pacemakers (PM) represent an effective treatment for symptomatic bradycardias cause by sinus node disease (SND) and atrioventricular block (AVB). For many years, the apical region of the right ventricle (RV) was one of the most frequently used sites in conventional implants due to its accessibility and lead cable stability 1 . However, in spite of the evident improvement in quality of life for most patients with an artificial implant, the left bundle-branch block (LBBB) induced by right ventricular apical pacing (RVAP) can cause hemodynamic, structural and functional alterations in the heart, with deleterious consequences on the clinical evolution of some patients 2, 3 .
The cardiac pacing at any point of the ventricle alters the natural heart activation and contraction pattern, as the stimulus conduction velocity is slower across the ventricular myocardium, when compared to that resulting from the specialized His-Purkinje system 4 .
Studies have demonstrated that, in response to an artificial pacing, the myocardial fibers contract erratically, resulting in heterogeneous stretching of myocardial segments that can interfere with the metabolism of the cardiac cell and cause global deterioration of the organ function 5, 6 . Hence, it could be presupposed that an abnormal electrical ventricular activation sequence associated to the inappropriate stretching of ventricular walls could result in dyssynchrony between the electrical ventricular activity and its contractility, determining, in the long term, ventricular dysfunction, neurohumoral alterations and increased cardiac morbidity and mortality.
Based on this hypothesis, the main objective of the present study was to evaluate the presence of ventricular dyssynchrony (VD) after long-term RVAP and its effects on brain natriuretic peptide (BNP) levels in clinically stable patients with no significant LV dysfunctions.
Methods
The study was carried out at the Pacemaker Laboratory of the Service of Cardiology of Hospital das Clínicas da Universidade Federal de Minas Gerais (UFMG) and the Echocardiography Center of Hospital Socor, after approval by the Ethical Committee of UFMG and the hospitals involved in the study. All patients signed the Free and Informed Consent form.
From June 2007 to March 2008, 85 Chagasic and nonChagasic patients were consecutively selected during routine telemetric assessments carried out at the aforementioned laboratory, who had been submitted to single or dualchamber pacemaker implantation with RVAP, and depended on artificial pacing (percentage of RV pacing ≥ 80%) , with a LBBB pattern of ventricular activation at the surface electrocardiogram (ECG).
Patients of both sexes aged 18 to 75 years, with NYHA functional class I or II and left ventricular ejection fraction (LVEF) ≥ 35% were included. Preexisting diseases and medications currently being used were identified.
Systemic arterial hypertension (SAH) was defined as a clinical history of hypertension and systolic blood pressure (SBP) levels ≥ 140 mmHg or diastolic blood pressure (DBP) ≥ 90 mmHg. Only controlled hypertensive and normotensive individuals were included in the study.
Diabetes mellitus was defined as a clinical history of diabetes and regular use of oral hypoglycemiants and/or insulin and only diabetic patients with controlled glycemic levels were included in the study.
Chagas' disease was identified by the presence of at least two distinct positive serological tests (ELISA, indirect hemagglutination or indirect immunofluorescence test) and relevant epidemiological history.
Kidney function was assessed through creatinine level measurement requested by the assistant physicians during the routine clinical/cardiologic follow-up.
The exclusion criteria considered coronary artery disease, characterized by the presence of chest angina and/or evidence of LV segmental contractility impairment at the echocardiogram, atrial fibrillation (AF), chronic obstructive pulmonary disease (COPD), pregnancy, recent heart surgery (less than 4 weeks) or refusal to participate in the study.
Analysis of the QRS complex and chest X-ray
The duration of the QRS complex consisted in the measurement of the time interval between the emission of the pacemaker spike and the end of the QRS complex (ms), assessed at the surface ECG D2 derivation.
The position of the ventricular lead-electrode was verified through a chest X-ray in the posteroanterior and profile views.
Echocardiographic study
The echocardiographic study protocol consisted in obtaining one and two-dimensional images with pulsed and continuous Doppler guided by color flow mapping, in addition to tissue Doppler, including Tissue Synchronization Imaging (TSI), with analysis of 12 segments.
The evaluations were carried out by en experienced professional in a Vivid 7 equipment (GE Vingmed Ultrasound AS, Horten, Norway), equipped with an electronic transducer of variable frequency (4 to 12 MHz) and high resolution. 6. IVSLW delay -Contraction delay between the interventricular septum and the lateral wall also obtained through TSI (cutoff ≥ 65 ms);
BNP measurement
BNP measurement was carried out in a venous blood sample, preferably obtained from the antecubital vein with the patient in the supine position for 30 minutes, before the echocardiogram was performed, with the examiner blinded for the results. Blood pressure (BP) and heart rate (HR) were measured before the collection. The whole blood samples were collected into plastic tubes containing EDTA (1 mg/ ml of blood) and immediately processed using the Triage™ BNP Test kits (Biosite™ Inc., San Diego, USA). In the present study, the cutoff was defined as 60 pg/ml for BNP levels, which was based on previous studies of Chagasic patients with preserved LV function 8, 9 .
Statistical analysis
The categorical variables were described by proportions and the continuous by means and standard deviations, medians and interquartile intervals, according to the distribution pattern. Uni-and multivariate linear regression analyses were used, considering BNP levels as the dependent variable. The level of statistical significance was defined for p values < 0.05.
Results
Only clinically compensated patients with NYHA functional class I or II were included in the study. There was a predominance of dual-chamber pacing (74%) and the median implant time was 63 months (1 -137 months), and 94% of the sample had been undergoing artificial pacing for six months or more. Total Atrioventricular Block (TAVB) was the most common indication for the implant (85%) and in 48 patients (56%) Chagas' disease was the cause of the underlying heart disease. The mean QRS duration was 139 ± 14.2 ms and none of the patients had significant LV dysfunction (mean LVEF = 51.8 ± 8%).
Regarding the RV, its mean performance indices were within the normal range, even after the analysis of the subgroup of patients with LVEF ≤ 40%. Its mean ejection fraction was 56.4 ± 11.2%.
BNP level median was 38.9 pg/ml with a minimum measured level of 5 pg/ml and a maximum level of 581 pg/ ml. In 34 patients (40%), these levels were considered to be high (cutoff = 60 pg/ml). The main clinical and demographic characteristics and echocardiographic parameters are shown in Table 1 .
Interventricular dyssynchrony was observed in 49 patients (59.8%), considering the median of the interventricular delay. Significant intraventricular dyssynchrony was observed in 77 patients (90.6%), when the analyzed parameter was the median of the LV pre-ejection time, as well as when the standard deviation and the maximum difference of systolic peaks measured in the 12 myocardial segments were analyzed. Similarly, the median of the contraction delay between the interventricular septum and the lateral wall was significant in 31 patients (36.5%) ( Table 2) .
At the univariate analysis, the QRS duration, time of implant, Chagas disease, arterial hypertension and most of the echocardiographic variables did not have a significant correlation with BNP levels. However, age (r = 0.33, p = 0.002) and LVEF (r = -0.28, p = 0.010) were significantly correlated with this parameter. A significant correlation was also observed between the measurement of the LV preejection time (r = 0.27, p = 0.013) and BNP levels ( Figure  1 ). All other measurements performed to assess VD did not show a significant correlation with BNP levels, regardless of the echocardiographic technique used ( Table 3 ). The positive association between LVPET and BNP levels remained even when the first was analyzed as a categorical variable, using the cutoff recommended for the diagnosis of VD according to the current literature (≥ 140 ms) (Figure 2 ).
At the multiple linear regression analysis, the LVPET remained as the only significant and independent predictor of BNP levels, even after adjustment for covariables, such as age and LVEF. Therefore, the linear regression model obtained disclosed that the older the patient, the more severe the LV dysfunction and the longer the LV pre-ejection time (starting at 140 ms), on average, the higher the BNP levels.
Although it was not the main objective of the present study, an analysis between the subgroups of Chagasic and Non-Chagasic patients was performed, as well as between the different pacing modes, DDD and VVI. However, no significant differences were observed in this series between the groups when the clinical, electrocardiographic and echocardiographic variables were evaluated, except for the mean LVEF, which was lower in Chagasic patients (p = 0,035).
Discussion
The present study showed a high frequency of VD in patients with pacemakers submitted to long-term right ventricular apical pacing who were clinically stable, in addition to a significant correlation between the LV pre-ejection time, which is a measure of intraventricular dyssynchrony and BNP levels.
The study group was characterized by age of 58.5 ± 12.6 years, predominance of Chagasic patients and absence 
BNPLn Left ventricular pre-ejection time (ms)
blockers and diuretics by more than 80% of the assessed patients indicates that all were submitted to optimized clinical treatment and were NYHA functional class I or II.
Around 40% of the patients had high levels of BNP, considering 60 pg/ml the cutoff used for the measured levels. This information was based on a previous study that analyzed Chagasic patients with preserved ventricular function and observed similar mean BNP levels between the control group and patients with LVEF > 40%. Significantly higher levels were found in patients with LVEF ≤ 40%
.
In accordance with other studies 9, 10 , it was observed that an increase in BNP levels was correlated with an increase in age (r = 0.33, p = 0.002) and LVEF worsening (r = -0.28, p = 0.010). However, considering that most of the sample was NYHA functional class I, more than the increase in LV filling pressures, the VD observed in the study also contributed to the increase in BNP levels. This fact was demonstrated by the significant correlation between the LV pre-ejection time and BNP (r = 0.38, p < 0.0001), regardless of LVEF and age.
Previous studies have demonstrated that dyssynchronous ventricular activation can contribute to asymmetric hypertrophy, myofibrillar disarray, increase in catecholamine concentrations, neurohumoral activation and regional perfusion disorders 5 . The studies MOST
11
, DAVID 12 and MADIT II 13 , in turn, indicated that VD can create an anatomofunctional substrate capable of impairing heart function in the long term, by observing an increase in the risk of AF, mitral regurgitation and hospital admissions due to heart failure in patients with a high percentage of right ventricular paced beats, particularly those with ventricular dysfunction prior to the implant 14 . However, whether VD is an acute phenomenon that could deteriorate LV function in the long term and, consequently, result in HF in the absence of cardiomyopathy, remains to be clarified 15, 16 .
Our results are in accordance, however, with those of other studies that verified that VD secondary to long-term RVAP can impair the LV systolic and diastolic functions and contribute to the increase in BNP levels. According to Chiladakis et al 17 , the increase in the left ventricular-end systolic volume and severity detected in patients with RVAP, as well as initial signs of HF in patients with TAVB and normal LVEF, after RVAP for 6.5 ± 5.7 years 18, 19 .
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Currently, the VD caused by RVAP can be quantified by several echocardiographic techniques. Although many types of measurements can be used, the most simple and routine ones have shown a good performance in multicentric assessments 20 . The LV pre-ejection time, for instance, assessed in the present study, is useful to quantify intraventricular dyssynchrony with good reproducibility according to previous studies, such as the CARE-HF study 21 . Recently, Sá et al 22 observed the prolonging of this measurement in a small group of patients, who were also Chagasic with normal LVEF, throughout an eight-month period. The authors observed that although the LVPET measurements did not reach the cutoff required for the diagnosis of VD (≥ 140 ms), this was the only assessed VD measure that showed increases throughout follow-up. It is noteworthy the fact that, in the aforementioned study, the septal pacing predominated over the apical one, which seems to be more deleterious.
In addition to LVPET, which was altered in more than 90% of the sample, the other echocardiographic measures assessed in the study also identified inter-and intraventricular dyssynchrony alterations, disclosing the high frequency of this disorder in patients submitted to long-term RVAP. Indices such as the interventricular delay, maximum difference and standard deviation of the 12 segments were altered in more than 50% of the sample. However, in spite of the usefulness of the several echocardiographic techniques employed, including Tissue Synchronization Imaging, to quantify VD, no significant isovolumetric relaxation time caused by RVAP in patients with normal LVEF contributed to these findings. Other authors also verified a significant correlation between BNP levels and VD association between these measures and BNP serum levels were observed in this group of patients, in opposition to LVPET.
Our results corroborate current discussions, especially in the field of CRT, which aim at answering whether the echocardiographic measures used to date in the analysis of VD are the ones that can better define its presence. Two important prospective and multicentric studies, PROSPECT 23 and ReThinQ 24 , did not find any correlation between VD measures and the benefits of CRT when selecting candidates to the procedure according to echocardiographic criteria. The importance of technical factors that contribute for these findings has been highlighted, especially by aspects related to the feasibility and reproducibility of the methods used. It is a consensus, however, that the TSI technique must not be considered unproductive for the VD analysis, but technological advances are necessary for less operatordependent approaches 20 .
Limitations
As this is a cross-sectional study, patients with PM were assessed at a certain point during their clinical follow-up, which brings limitations to the results. Although our findings indicate an association between the increase in BNP levels and VD secondary to long-term RVAP, the study design does not allow us to establish a causal association between these variables.
It is important to consider that BNP was assessed together with the VD measures, of which specific studies did not define the best indices or ideal cutoffs to perform its analysis and this is one of the reasons of the non-inclusion of the dyssynchrony measures proposed, until then, by the current Cardiac Resynchronization Guidelines 25 . In spite of that, it is a consensus in the current literature that the VD measures be used together with clinical criteria in the selection of candidates considered to be borderline for CRT 26 .
Limitations that are inherent to the Tissue Synchronization Imaging must be mentioned 7 . Among them are the systolic curves, not always contained within the ejection interval, multiple peaks resulting from a same myocardial segment and, in some instances, instead of a well-defined peak, the presence of a plateau, which made it difficult to determine the ideal point for the proposed measure.
Conclusions
Patients with PM and long-term RVAP have a high frequency of VD and in the present study, the intraventricular dyssynchrony was identified through the measurement of the LVPET in around 90% of the patients. Moreover, this measure showed to be an independent predictor of increased BNP levels, indicating that VD was capable of producing early neurohumoral alterations in patients with no significant LV dysfunction.
Further studies are necessary to define whether the VD identified at the echocardiogram or the increase in BNP levels in patients with PM submitted to long-term RVAP are capable of predicting an unfavorable evolution.
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